RPA2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.961630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.234400E-01
Normal-vs-Stage2
1.454640E-01
Normal-vs-Stage3
1.682640E-01
Normal-vs-Stage4
9.615400E-01
Stage1-vs-Stage2
8.017000E-01
Stage1-vs-Stage3
2.404400E-01
Stage1-vs-Stage4
2.086400E-02
Stage2-vs-Stage3
1.978220E-01
Stage2-vs-Stage4
1.046020E-01
Stage3-vs-Stage4
2.367800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.134400E-01
Normal-vs-AfricanAmerican
4.094600E-01
Normal-vs-Asian
2.955800E-01
Caucasian-vs-AfricanAmerican
7.928600E-01
Caucasian-vs-Asian
1.202450E-01
AfricanAmerican-vs-Asian
9.663900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.026360E-01
Normal-vs-Female
3.273400E-01
Male-vs-Female
3.714800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.110000E-01
Normal-vs-Age(41-60Yrs)
3.076600E-01
Normal-vs-Age(61-80Yrs)
2.014800E-01
Normal-vs-Age(81-100Yrs)
3.388800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.226400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.000000E+00
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.495600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.271040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.588300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.726560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.733800E-02
Normal-vs-Daily Drinker
2.422600E-01
Normal-vs-Weekly Drinker
3.551200E-01
Normal-vs-Occasional Drinker
7.238800E-01
Normal-vs-Social Drinker
3.011200E-01
Non Drinker-vs-Daily Drinker
5.738100E-02
Non Drinker-vs-Weekly Drinker
5.678400E-01
Non Drinker-vs-Occasional Drinker
5.149700E-02
Non Drinker-vs-Social Drinker
1.924560E-01
Daily Drinker-vs-Weekly Drinker
6.178800E-01
Daily Drinker-vs-Occasional Drinker
4.071400E-01
Daily Drinker-vs-Social Drinker
8.051400E-01
Weekly Drinker-vs-Occasional Drinker
3.053800E-01
Weekly Drinker-vs-Social Drinker
7.658000E-01
Occasional Drinker-vs-Social Drinker
3.783200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.682600E-01
Normal-vs-Grade 2
7.814800E-01
Normal-vs-Grade 3
7.639400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.627600E-01
Grade 1-vs-Grade 3
9.351200E-01
Grade 1-vs-Grade 4
7.682600E-01
Grade 2-vs-Grade 3
4.691600E-01
Grade 2-vs-Grade 4
7.814800E-01
Grade 3-vs-Grade 4
7.639400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.493630E-01
Normal-vs-NonDiabetic
2.267000E-01
Diabetic-vs-NonDiabetic
6.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.331370E-01
Normal-vs-NoPancreatitis
2.393200E-01
Pancreatitis-vs-NoPancreatitis
7.234200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.349200E-01
Normal-vs-N1
1.665800E-01
N0-vs-N1
7.480600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.971200E-01
Normal-vs-TP53-NonMutant
3.580200E-01
TP53-Mutant-vs-TP53-NonMutant
4.190800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
